Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Alterola Biotech, Inc./ 10-K

Annual Report · 10-K

Alterola Biotech, Inc.

ABTIOTCEQUITYCurrent

Annual Report

Filed Jul 18, 2024Accepted Jul 17, 2024, 2:04 PM EDTCIK 1442999Accession 0001663577-24-000211
View company →Permanent SEC source ↗
Share

Company context

Current securities

ABTIOTC · EQUITY · Current

Recent company filings

  1. 15-15D filingJun 30, 2025
  2. Entry into a Material Definitive Agreement · Completion of Acquisition or Disposition of Assets · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD DisclosureJun 30, 2025
  3. NT 10-Q filingFeb 14, 2025
  4. 10-Q filingNov 29, 2024
  5. 10-Q/A filingNov 25, 2024

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗